Syndax Pharmaceuticals (SNDX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to -$1.5 million.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments fell 698.18% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 698.18%. This contributed to the annual value of -$2.0 million for FY2024, which is 2104.85% up from last year.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$1.5 million in Q3 2025, which was down 698.18% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Syndax Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of -$732000.0 in Q2 2021 and a low of -$3.3 million during Q3 2023
- In the last 5 years, Syndax Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$1.9 million in 2022 and averaged -$1.9 million.
- As far as peak fluctuations go, Syndax Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 118333.33% in 2021, and later surged by 5857.19% in 2024.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$924000.0 in 2021, then plummeted by 113.42% to -$2.0 million in 2022, then dropped by 27.69% to -$2.5 million in 2023, then grew by 21.05% to -$2.0 million in 2024, then grew by 26.01% to -$1.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.5 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$2.9 million for Q1 2025.